A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Public ClinicalTrials.gov record NCT03465904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main objective of this study is to have Phase III evidences of the efficacy of the Cefaly® Abortive Program device used at home for 2 hours to treat a migraine attack. This randomized, double-blind, sham-controlled trial will study the abortive treatment of migraine using the Cefaly® Abortive Program device.
Study identification
- NCT ID
- NCT03465904
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 607 participants
Conditions and interventions
Conditions
Interventions
Device
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 10, 2018 (Actual)
- Primary completion
- Jan 11, 2019 (Actual)
- Completion
- Jan 11, 2019 (Actual)
- Last update posted
- Dec 11, 2024
2018 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Consortium | Tempe | Arizona | 85283 | — |
| Pharmacology Research Institute | Encino | California | 91316 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Meridian Clinical Research (Savannah Neurology) | Savannah | Georgia | 31406 | — |
| Meridian Clinical Research (Rockville Neurology) | Rockville | Maryland | 20854 | — |
| Clinical Research Consortium | Las Vegas | Nevada | 89119 | — |
| Rochester Clinical Research | Rochester | New York | 14609 | — |
| Rapid Medical Research Inc. | Cleveland | Ohio | 44122 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03465904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 11, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03465904 live on ClinicalTrials.gov.